Renaissance Technologies’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Buy |
1,862,200
+706,200
| +61% | +$1.6M | 0.01% | 1636 |
|
|
2025
Q1 | $735K | Sell |
1,156,000
-190,800
| -14% | -$121K | ﹤0.01% | 2576 |
|
|
2024
Q4 | $1.39M | Buy |
1,346,800
+331,800
| +33% | +$342K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $1.2M | Sell |
1,015,000
-168,022
| -14% | -$198K | ﹤0.01% | 2332 |
|
|
2024
Q2 | $1.44M | Sell |
1,183,022
-49,778
| -4% | -$60.7K | ﹤0.01% | 2093 |
|
|
2024
Q1 | $2.69M | Sell |
1,232,800
-92,900
| -7% | -$203K | ﹤0.01% | 1827 |
|
|
2023
Q4 | $2.06M | Buy |
1,325,700
+395,600
| +43% | +$613K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $1.2M | Sell |
930,100
-192,300
| -17% | -$248K | ﹤0.01% | 2179 |
|
|
2023
Q2 | $1.93M | Buy |
1,122,400
+272,100
| +32% | +$468K | ﹤0.01% | 2018 |
|
|
2023
Q1 | $1.28M | Sell |
850,300
-490,474
| -37% | -$741K | ﹤0.01% | 2304 |
|
|
2022
Q4 | $2.15M | Sell |
1,340,774
-464,826
| -26% | -$744K | ﹤0.01% | 2023 |
|
|
2022
Q3 | $2.62M | Buy |
1,805,600
+351,339
| +24% | +$509K | ﹤0.01% | 1854 |
|
|
2022
Q2 | $2.66M | Buy |
1,454,261
+558,361
| +62% | +$1.02M | ﹤0.01% | 1985 |
|
|
2022
Q1 | $2.39M | Buy |
895,900
+390,400
| +77% | +$1.04M | ﹤0.01% | 2101 |
|
|
2021
Q4 | $2.19M | Sell |
505,500
-389,100
| -43% | -$1.68M | ﹤0.01% | 2068 |
|
|
2021
Q3 | $4.55M | Sell |
894,600
-131,600
| -13% | -$670K | 0.01% | 1531 |
|
|
2021
Q2 | $6.5M | Sell |
1,026,200
-426,368
| -29% | -$2.7M | 0.01% | 1472 |
|
|
2021
Q1 | $11.2M | Sell |
1,452,568
-611,932
| -30% | -$4.73M | 0.01% | 1120 |
|
|
2020
Q4 | $13.5M | Sell |
2,064,500
-240,100
| -10% | -$1.57M | 0.01% | 969 |
|
|
2020
Q3 | $15.3M | Sell |
2,304,600
-46,071
| -2% | -$306K | 0.02% | 879 |
|
|
2020
Q2 | $19.6M | Buy |
2,350,671
+142,671
| +6% | +$1.19M | 0.02% | 827 |
|
|
2020
Q1 | $16.9M | Buy |
2,208,000
+144,729
| +7% | +$1.11M | 0.02% | 862 |
|
|
2019
Q4 | $17.1M | Buy |
2,063,271
+530,971
| +35% | +$4.41M | 0.01% | 1090 |
|
|
2019
Q3 | $11.3M | Buy |
1,532,300
+125,300
| +9% | +$925K | 0.01% | 1312 |
|
|
2019
Q2 | $15.8M | Buy |
1,407,000
+116,400
| +9% | +$1.31M | 0.01% | 1108 |
|
|
2019
Q1 | $13.9M | Sell |
1,290,600
-27,200
| -2% | -$292K | 0.01% | 1188 |
|
|
2018
Q4 | $19.9M | Sell |
1,317,800
-202,700
| -13% | -$3.06M | 0.02% | 883 |
|
|
2018
Q3 | $28.1M | Buy |
1,520,500
+109,000
| +8% | +$2.02M | 0.03% | 717 |
|
|
2018
Q2 | $32.3M | Buy |
1,411,500
+450,300
| +47% | +$10.3M | 0.04% | 645 |
|
|
2018
Q1 | $27.3M | Buy |
961,200
+246,100
| +34% | +$7M | 0.03% | 762 |
|
|
2017
Q4 | $15.1M | Buy |
715,100
+177,200
| +33% | +$3.74M | 0.02% | 1138 |
|
|
2017
Q3 | $9.77M | Buy |
537,900
+127,000
| +31% | +$2.31M | 0.01% | 1341 |
|
|
2017
Q2 | $6.37M | Buy |
410,900
+176,100
| +75% | +$2.73M | 0.01% | 1547 |
|
|
2017
Q1 | $4.06M | Buy |
234,800
+143,600
| +157% | +$2.48M | 0.01% | 1818 |
|
|
2016
Q4 | $1M | Buy |
+91,200
| New | +$1M | ﹤0.01% | 2536 |
|